YM BioSciences Inc.

Hematology and orphan or untreated diseases emerged as themes for the US Food and Drug Administration’s mid-June approvals and recent applications. Alnylam Pharmaceuticals Inc. demonstrated the grow

GlaxoSmithKline plc has hit the acquisition trail to buy Sierra Oncology, Inc. and bolster its late-stage cancer pipeline with the promising myelofibrosis drug momelotinib. The UK major is splashin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. NewAmsterdam’s Plans For Obicetrapib In

Rakuten Aspyrian Inc. has raised $150m in Series C venture capital to fund a Phase III clinical trial that it intends to start before the end of this year to test its laser-activated antibody conjuga